Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey
H. H. Steiner(Nuremberg Hospital), José Manuel Cabezudo Artero(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Marco Stein(Justus-Liebig-Universität Gießen), Philippe Schucht(University of Bern), Dorothee Wiewrodt(University Hospital Münster), Sam Eljamel(Ninewells Hospital), Ulf Nestler(Leipzig University), Ante Melada(University Hospital Centre Zagreb), Nunzio Platania(Rigshospitalet), Alessandro Della Puppa(Azienda Ospedale - Università Padova), Walter Stummer(University of Münster), Christian Ewald(Jena University Hospital), Thomas Santarius(University of Cambridge), Aurelia Peraud(University Hospital Münster), Angela Brentrup(University Hospital Münster), Søren Cortnum(Aalborg University Hospital), Andrew J. Martin(St George's Hospital), Laura González-García(Atkins (United States)), Matthias Preuß(University Hospital Münster), Floriano Rodrigues(Medac (Germany)), Jane Skjøth‐Rasmussen(University of Cambridge), John Caird(Temple Street Children's University Hospital)
Cited by 102
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k